Markets

bluebird bio (BLUE) Looks Good: Stock Adds 8.5% in Session

An image of stock prices rising and declining in value
Credit: Shutterstock photo

bluebird bio, Inc.BLUE was a big mover last session, as the company saw its shares rise almost 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of$75.35 -$90.45 in the past one-month time frame.

The upside is likely to have been driven by the company's recently released updated results from an ongoing early-stage clinical trial in relapsed/refractory multiple myeloma.

The company has seen seven positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past month, suggesting that more solid trading could be ahead for Intercept Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Bluebird bio currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

bluebird bio, Inc. Price and Consensus

bluebird bio, Inc. Price and Consensus | bluebird bio, Inc. Quote

A better-ranked stock in the Medical - Biomedical and Geneticsindustry is VIVUS, Inc.(VVUS), which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Is BLUE going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

bluebird bio, Inc. (BLUE): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BLUE

Other Topics

Investing Stocks